Daptomycin Patent Expiration
Daptomycin was first introduced by Cubist Pharmaceuticals Llc
Daptomycin Patents
Given below is the list of patents protecting Daptomycin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Dapzura Rt | US11173189 | Daptomycin formulations containing a combination of sorbitol and mannitol | Mar 11, 2041 | Baxter Hlthcare Corp |
| Daptomycin | US11759497 | Daptomycin formulations | Aug 28, 2038 | Hikma |
| Daptomycin | US12053502 | Daptomycin formulations | Aug 28, 2038 | Hikma |
| Daptomycin | US10357535 | Daptomycin formulations and uses thereof | Sep 11, 2033 | Hospira |
| Daptomycin | US9655946 | Daptomycin formulations and uses thereof | Sep 11, 2033 | Hospira |
| Cubicin | US9138456 | Lipopeptide compositions and related methods | Nov 23, 2030 | Cubist Pharms Llc |
| Cubicin Rf | US9138456 | Lipopeptide compositions and related methods | Nov 23, 2030 | Cubist Pharms Llc |
| Cubicin | US8003673 | Daptomycin for the treatment of biofilm and catheter salvage | Sep 04, 2028 | Cubist Pharms Llc |
| Cubicin | US8058238 | High purity lipopeptides |
Nov 28, 2020
(Expired) | Cubist Pharms Llc |
| Cubicin | US8129342 | High purity lipopeptides |
Nov 28, 2020
(Expired) | Cubist Pharms Llc |
| Cubicin | US6468967 | Methods for administration of antibiotics |
Sep 24, 2019
(Expired) | Cubist Pharms Llc |
| Cubicin | US6852689 | Methods for administration of antibiotics |
Sep 24, 2019
(Expired) | Cubist Pharms Llc |
| Cubicin | USRE39071 | Anhydro-and isomer-a-21978c cyclic peptides |
Jun 15, 2016
(Expired) | Cubist Pharms Llc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Daptomycin's patents.
Latest Legal Activities on Daptomycin's Patents
Given below is the list recent legal activities going on the following patents of Daptomycin.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Email Notification Critical | 20 Sep, 2023 | US11759497 |
| Recordation of Patent eGrant | 19 Sep, 2023 | US11759497 |
| Patent eGrant Notification | 19 Sep, 2023 | US11759497 |
| Recordation of Patent Grant Mailed Critical | 19 Sep, 2023 | US11759497 |
| Patent Issue Date Used in PTA Calculation Critical | 19 Sep, 2023 | US11759497 |
| Mail Patent eGrant Notification | 19 Sep, 2023 | US11759497 |
| Email Notification Critical | 01 Sep, 2023 | US11759497 |
| Issue Notification Mailed Critical | 30 Aug, 2023 | US11759497 |
| Dispatch to FDC | 09 Aug, 2023 | US11759497 |
| Application Is Considered Ready for Issue Critical | 09 Aug, 2023 | US11759497 |
Daptomycin's Family Patents
Explore Our Curated Drug Screens
Daptomycin Generic API Manufacturers
Several generic applications have been filed for Daptomycin. The first generic version for Daptomycin was by Hospira Inc and was approved on Sep 12, 2014. And the latest generic version is by Biocon Pharma Ltd and was approved on Aug 29, 2024.
Given below is the list of companies who have filed for Daptomycin generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 2 different strengths of generic version for Daptomycin. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Jun 24, 2019 |
| 350MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Jul 12, 2019 |
2. ASPIRO
Aspiro Pharma Ltd has filed for 2 different strengths of generic version for Daptomycin. Given below are the details of the strengths of this generic introduced by Aspiro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Sep 23, 2022 |
| 350MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Dec 23, 2022 |
Manufacturing Plant Locations New
Aspiro's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aspiro as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
3. BE PHARMS
Be Pharmaceuticals Ag has filed for 2 different strengths of generic version for Daptomycin. Given below are the details of the strengths of this generic introduced by Be Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Jun 26, 2019 |
| 350MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Aug 20, 2020 |
4. BIOCON PHARMA
Biocon Pharma Ltd has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Biocon Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Aug 29, 2024 |
Manufacturing Plant Locations New
Biocon Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Biocon Pharma as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
5. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Daptomycin. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Prescription | INTRAVENOUS | AP | May 1, 2019 |
| 350MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Aug 31, 2020 |
6. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Sep 2, 2021 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
7. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 2 different strengths of generic version for Daptomycin. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Apr 11, 2018 |
| 350MG/VIAL | powder | Discontinued | INTRAVENOUS | N/A | Aug 1, 2024 |
Manufacturing Plant Locations New
Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
8. HAINAN POLY PHARM
Hainan Poly Pharmaceutical Co Ltd has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Hainan Poly Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Aug 18, 2022 |
Manufacturing Plant Locations New
Hainan Poly Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Hainan Poly Pharm as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| China |
| |||
9. HANGZHOU ZHONGMEI
Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Hangzhou Zhongmei.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Nov 26, 2021 |
Manufacturing Plant Locations New
Hangzhou Zhongmei's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Hangzhou Zhongmei as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| China |
| |||||
10. HENGRUI PHARMA
Jiangsu Hengrui Pharmaceuticals Co Ltd has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Hengrui Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Aug 22, 2019 |
11. HISUN PHARM HANGZHOU
Hisun Pharmaceutical Hangzhou Co Ltd has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Hisun Pharm Hangzhou.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Apr 21, 2021 |
12. HOSPIRA
Hospira Inc has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Hospira.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Discontinued | INTRAVENOUS | N/A | Sep 12, 2014 |
Manufacturing Plant Locations New
Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Australia |
| |||||||||||||
| United States |
| |||||||||||||
| Dominican Republic (the) |
| |||||||||||||
13. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 2 different strengths of generic version for Daptomycin. Given below are the details of the strengths of this generic introduced by Meitheal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Jun 29, 2021 |
| 350MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Jun 29, 2021 |
14. MYLAN
Mylan Pharmaceuticals Inc A Viatris Co has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Aug 7, 2023 |
Manufacturing Plant Locations New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
| Canada |
| |||||||||||||||||
| Ireland |
| |||||||||||||||||
15. MYLAN LABS LTD
Mylan Laboratories Ltd has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Jun 5, 2018 |
16. QILU PHARM HAINAN
Qilu Pharmaceutical Hainan Co Ltd has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Qilu Pharm Hainan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL
(reference standard) | powder | Prescription | INTRAVENOUS | AP | Aug 24, 2021 |
17. SAGENT PHARMS INC
Sagent Pharmaceuticals Inc has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Sagent Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Nov 15, 2019 |
18. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Mar 25, 2016 |
19. XELLIA PHARMS APS
Xellia Pharmaceuticals Aps has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Xellia Pharms Aps.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG/VIAL | powder | Prescription | INTRAVENOUS | AP | Jun 15, 2016 |